$1.88
-0.07-3.59%
Last update: Oct 16, 4:12 AM
$1.91
-0.04-2.05%
Polaryx Therapeutics Inc (PLYX) Stock Price, Quote, News & History
PLYXNASDAQ
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Polaryx Therapeutics (NASDAQ:PLYX) through any online brokerage.
Other companies in Polaryx Therapeutics’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
Polaryx Therapeutics has a consensus price target of $7.50.
The stock price for Polaryx Therapeutics (NASDAQ: PLYX) is $1.91 last updated October 16, 2026 at 4:12 AM EDT.
There are no upcoming dividends for Polaryx Therapeutics.
Polaryx Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Polaryx Therapeutics.
Polaryx Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Polaryx Therapeutics Inc is a clinical-stage biotechnology company committed to the discovery, development, and commercialization of novel, disease-modifying therapies for rare, pediatric LSDs. Its therapeutic approach focuses on treating the...
